Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome

Sadeghimakki, Roham and Tahrani, Abd A. (2023) Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome. The Lancet regional health. Europe, 35 (100796). pp. 1-2. ISSN 2666-7762

[img]
Preview
Text
1-s2.0-S2666776223002156-main.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0.

Download (155kB) | Preview
Official URL: https://doi.org/10.1016/j.lanepe.2023.100796

Abstract / Description

Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality.

Item Type: Article
Uncontrolled Keywords: impaired lung function; metabolic syndrome; cardiopulmonary morbidity; cardiopulmonary mortality; comments; commentaries
Subjects: 600 Technology > 610 Medicine & health
Department: School of Human Sciences
SWORD Depositor: Pub Router
Depositing User: Pub Router
Date Deposited: 04 Jan 2024 14:43
Last Modified: 04 Jan 2024 14:43
URI: https://repository.londonmet.ac.uk/id/eprint/8982

Downloads

Downloads per month over past year



Downloads each year

Actions (login required)

View Item View Item